Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
Submitted by
admin
on March 31, 2023 - 10:16am
Source:
Motley Fool
News Tags:
Skyrizi
AbbVie
clinical trials
ulcerative colitis
Headline:
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
snippet:
Skyrizi’s recently announced phase 3 clinical trial results to treat ulcerative colitis demonstrate that it is effective.
An ulcerative colitis indication in the U.S. could be a blockbuster all on its own.
AbbVie is attractively valued at the current share price.
Do Not Allow Advertisers to Use My Personal information
